Literature DB >> 17963873

Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone.

Antonio Tucci1, Michele Bisceglia, Massimo Rugge, Primiano Tucci, Attilio Marchegiani, Giovanni Papadopoli, Alessia Spada, Antonio Villani, Gianmaria Pennelli, Pietro Fusaroli, Giancarlo Caravelli, Tiziana Catalano, Vincenzo Cennamo, Massimo Cianci, Corrado De Fanis, Carlo Fabbri, Giuseppe Feliciangeli, Giuseppe Gizzi, Antonio Spadaccini, Giancarlo Caletti.   

Abstract

BACKGROUND: Gastric juice is usually discarded during upper-GI endoscopy.
OBJECTIVE: By using a novel device, the Mt 21-42, we evaluated the potential of this important organic fluid in clinical practice, exploring its contribution to the diagnosis of Helicobacter pylori infection and atrophic gastritis of the oxyntic mucosa (AGOM). DESIGN AND PATIENTS: A multicenter study (17,907 patients; 10 endoscopy units) estimated the frequency of diagnosis of AGOM and H pylori infection in routine endoscopic practice. A prospective study (216 patients) at 1 of these units aimed to determine the real prevalence of these conditions and the possible benefits of gastric juice analysis. We considered gastric juice pH and ammonium concentration, endoscopic and histologic features, serologic parameters for atrophy and H pylori, gastric acid secretion, and costs.
RESULTS: We found that H pylori infection and, even more markedly, AGOM were greatly underdiagnosed in routine endoscopic practice (20.1% and 0.8% vs 49.1% and 12.5% in the prospective study, respectively), because of the intrinsic limitations of the conventional tests and lack/inappropriateness of biopsy planning. Gastric-juice analysis proved to be a cheap, simple, and effective way to prevent such underdiagnosis and allowed detection of atrophic gastritis and H pylori in 96% and 98% of cases, and saved costs (cost-effectiveness ratio 209 vs 274-5047).
CONCLUSIONS: Gastric juice provided a valuable source of clinicopathologic information that, properly analyzed, allowed detection of the main risk factors for gastric cancer (H pylori and atrophic gastritis), overcoming the diagnostic limitations associated with these conditions and also producing time and cost savings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963873     DOI: 10.1016/j.gie.2007.03.1052

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  7 in total

Review 1.  Detection of digestive malignancies and post-gastrectomy complications via gastrointestinal fluid examination.

Authors:  Lei Huang; Aman Xu
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

2.  Real-time diagnosis of H. pylori infection during endoscopy: Accuracy of an innovative tool (EndoFaster).

Authors:  Guido Costamagna; Angelo Zullo; Alessandra Bizzotto; Cristiano Spada; Cesare Hassan; Maria Elena Riccioni; Clelia Marmo; Giuseppe Strangio; Teresa Antonella Di Rienzo; Giovanni Cammarota; Antonio Gasbarrini; Alessandro Repici
Journal:  United European Gastroenterol J       Date:  2015-10-13       Impact factor: 4.623

3.  Gastric juice miR-129 as a potential biomarker for screening gastric cancer.

Authors:  Xing Yu; Lin Luo; Yibo Wu; Xiuchong Yu; Yang Liu; Xuelin Yu; Xiaoyan Zhao; Xinjun Zhang; Long Cui; Guoliang Ye; Yanping Le; Junming Guo
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

4.  Association between Increased Gastric Juice Acidity and Sliding Hiatal Hernia Development in Humans.

Authors:  Hiroshi Kishikawa; Kayoko Kimura; Asako Ito; Kyoko Arahata; Sakiko Takarabe; Shogo Kaida; Takanori Kanai; Soichiro Miura; Jiro Nishida
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

5.  Helicobacter pylori-derived extracellular vesicles increased in the gastric juices of gastric adenocarcinoma patients and induced inflammation mainly via specific targeting of gastric epithelial cells.

Authors:  Hyun-Il Choi; Jun-Pyo Choi; Jiwon Seo; Beom Jin Kim; Mina Rho; Jin Kwan Han; Jae Gyu Kim
Journal:  Exp Mol Med       Date:  2017-05-12       Impact factor: 8.718

6.  Diagnostic Accuracy of EndoFaster® and Narrow-Band Imaging Endoscopy in Patients with Impaired Gastric Acid Secretion: A Real-Time Prospective Study.

Authors:  M Cazzato; G Esposito; G Galli; E Pilozzi; E Lahner; V D Corleto; A Zullo; E Di Giulio; B Annibale
Journal:  Gastroenterol Res Pract       Date:  2021-03-20       Impact factor: 2.260

7.  Clinical usefulness of the serological gastric biopsy for the diagnosis of chronic autoimmune gastritis.

Authors:  Antonio Antico; Marilina Tampoia; Danilo Villalta; Elio Tonutti; Renato Tozzoli; Nicola Bizzaro
Journal:  Clin Dev Immunol       Date:  2012-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.